LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Civitas Therapeutics

Similar companies to Civitas Therapeutics

Civitas Therapeutics Tech Stack

Media & News

Civitas Therapeutics's Email Address Formats

Civitas Therapeutics uses at least 1 format(s):
Civitas Therapeutics Email FormatsExamplePercentage
FLast@civitastherapeutics.comJDoe@civitastherapeutics.com
50%
FLast@civitastherapeutics.comJDoe@civitastherapeutics.com
50%

Frequently Asked Questions

What is Civitas Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Civitas Therapeutics's official website is civitastherapeutics.com and has social profiles on LinkedIn.

How much revenue does Civitas Therapeutics generate?

Minus sign iconPlus sign icon
As of November 2024, Civitas Therapeutics's annual revenue reached $63M.

What is Civitas Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Civitas Therapeutics's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Civitas Therapeutics have currently?

Minus sign iconPlus sign icon
As of November 2024, Civitas Therapeutics has approximately 11 employees across 1 continents, including North America. Key team members include Director Of Manufacturing: E. P.Director Of Manufacturing: P. E.Cmc Validation Manager: S. M.. Explore Civitas Therapeutics's employee directory with LeadIQ.

What industry does Civitas Therapeutics belong to?

Minus sign iconPlus sign icon
Civitas Therapeutics operates in the Biotechnology Research industry.

What is Civitas Therapeutics's email format?

Minus sign iconPlus sign icon
Civitas Therapeutics's email format typically follows the pattern of . Find more Civitas Therapeutics email formats with LeadIQ.
Civitas Therapeutics

Civitas Therapeutics

Biotechnology Research11-50 Employees

Civitas Therapeutics is a privately-held biopharmaceutical company focused on developing a robust pipeline of inhaled therapeutics with the clinically-proven ARCUS dry powder pulmonary delivery platform.  The company’s lead program, CVT-301, is being developed as adjunctive PRN therapy to provide Parkinson’s disease patients with rapid and reliable relief from intermittent debilitating motor fluctuations (OFF episodes).  

The ARCUS platform is a proprietary dry powder and device combination with a unique ability to deliver a large, precise dose independent of inspiratory flow rate from a simple, breath actuated device and is protected by a large intellectual property estate.

Section iconCompany Overview

SIC Code
2834 - Pharmaceutical Preparations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $50M$100M

    Civitas Therapeutics's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $50M$100M

    Civitas Therapeutics's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.